Please use this identifier to cite or link to this item: https://doi.org/10.2147/IDR.S172366
Title: Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics
Authors: Leong, H.N.
Kurup, A.
Tan, M.Y.
Kwa, A.L.H. 
Liau, K.H.
Wilcox, M.H.
Keywords: Antibiotics
Complicated skin and soft tissue infections
Methicillin-resistant staphylococcus aureus
Singapore
Issue Date: 2018
Publisher: Dove Medical Press Ltd.
Citation: Leong, H.N., Kurup, A., Tan, M.Y., Kwa, A.L.H., Liau, K.H., Wilcox, M.H. (2018). Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics. Infection and Drug Resistance 11 : 1959-1974. ScholarBank@NUS Repository. https://doi.org/10.2147/IDR.S172366
Rights: Attribution-NonCommercial 4.0 International
Abstract: Complicated skin and soft tissue infections (cSSTIs) represent the severe form of infectious disease that involves deeper soft tissues. Involvement of methicillin-resistant Staphylococcus aureus (MRSA) further complicates cSSTI with increased hospitalization, health care costs, and overall mortality. Various international guidelines provide recommendations on the management of cSSTIs, with the inclusion of newer antibiotics. This literature-based review discusses the overall management of cSSTI, including appropriate use of antibiotics in clinical practice. Successful treatment of cSSTIs starts with early and precise diagnosis, including identification of causative pathogen and its load, determination of infection severity, associated complications, and risk factors. The current standard-of-care for cSSTIs involves incision, drainage, surgical debridement, broad-spectrum antibiotic therapy, and supportive care. In recent years, the emergence of newer antibiotics (eg, ceftaroline, tigecycline, daptomycin, linezolid, etc) has provided clinicians wider options of antimicrobial therapy. Selection of antibiotics should be based on the drug characteristics, effectiveness, safety, and treatment costs, alongside other aspects such as host factors and local multidrug resistance rates. However, larger studies on newer antibiotics are warranted to refine the decision making on the appropriate antimicrobial therapy. Local Antimicrobial Stewardship Program strategies in health care settings could guide clinicians for early initiation of specific treatments to combat region-specific antimicrobial resistance, minimize adverse effects, and to improve outcomes such as reduction in Clostridium difficile infections. These strategies involving iv-to-oral switch, de-escalation to narrow-spectrum antibiotics, and dose optimization have an impact on the overall improvement of cSSTI therapy outcomes, especially in countries like Singapore that has a high disease burden. © 2018 Leong et al.
Source Title: Infection and Drug Resistance
URI: https://scholarbank.nus.edu.sg/handle/10635/210907
ISSN: 11786973
DOI: 10.2147/IDR.S172366
Rights: Attribution-NonCommercial 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_2147_IDR_S172366.pdf744.1 kBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

50
checked on Jan 26, 2023

Page view(s)

85
checked on Jan 26, 2023

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons